ACLS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Trinidad, M.
Right arrow Articles by Fitzpatrick, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Trinidad, M.
Right arrow Articles by Fitzpatrick, J.
Annals of Clinical and Laboratory Science, Vol 15, Issue 6, 475-481
Copyright © 1985 by Association of Clinical Scientists


Articles

Simultaneous detection of platelet and lymphocyte antibodies by slide enzyme immunoassay

MC Trinidad, E Cohen, and JE Fitzpatrick

The feasibility of using an enzyme immunoassay (EIA) to detect simultaneously the antibodies bound to platelets and lymphocytes on glass slides was investigated. A peroxidase-antiperoxidase (PAP) immune complex method was used in which lymphocytes and platelets were attached to glass slides by poly-L-lysine and the preparations were stored at -20 degrees C for subsequent assays. Test sera were incubated with the cells. Reagents linking the platelet and/or leukocyte antibody to the PAP enzyme marker were added, followed by a staining step to localize the antigen-antibody complex. Any brown staining of the perimeter of the cells and in the cytoplasm was considered indicative of a positive reaction. A total of 146 sera were assayed; 36 were from Roswell Park Memorial Institute (RPMI) plasmapheresis donors, 75 were from RPMI oncology patients, and 35 were from other laboratories. The PAP method agreed with complement lysis inhibition assay (CLIA) by 97 percent in detecting antibodies capable of reacting with platelets while concordance with complement dependent lymphocytotoxicity (CDL) was 81 percent. With further investigation, this method could be adapted as a screening procedure in the clinical laboratory. It is easy, inexpensive, and could be performed in a few hours.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1985 by the Association of Clinical Scientists.